Heart drug digoxin tested as potential ALS treatment
NCT ID NCT07047209
First seen Oct 31, 2025 · Last updated May 25, 2026 · Updated 30 times
Summary
This study tests whether digoxin, a heart medication, is safe and can slow nerve damage in people with ALS. About 40 adults with early-stage ALS will take digoxin for 24 weeks. Researchers will monitor side effects and measure blood markers of nerve health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS - AMYOTROPHIC LATERAL SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
MGH
Boston, Massachusetts, 02114, United States
-
Northwestern Universsity
Chicago, Illinois, 60611, United States
-
Nova Southeastern University
Davie, Florida, 33314, United States
Conditions
Explore the condition pages connected to this study.